Severe injury=GCS<8
B. Level II
Blood pressure should be monitored and hypotension (systolic blood pressure 90 mm Hg) avoided.
C. Level III
Oxygenation should be monitored and hypoxia (PaO
2 60 mm Hg or O2 saturation 90%) avoided.
B. Level II
Mannitol is effective for control of raised intracranial pressure (ICP) at doses of 0.25 gm/kg to 1 g/kg body weight. Arterial hypotension (systolic blood pressure 90 mm Hg) should be avoided.
C. Level III
Restrict mannitol use prior to ICP monitoring to patients with signs of transtentorial herniation or progressive neurological deterioration not attributable to extracranial causes.
C. Level III
Pooled data indicate that prophylactic hypothermia isnot significantly associated with decreased mortality when compared with normothermic controls. However, preliminary findings suggest that a greater decrease in mortality risk is observed when target temperatures are maintained for more than 48 h. Prophylactic hypothermia is associated with significantly higher Glasgow Outcome Scale (GOS) scores when compared to scores for normothermic controls.
B. Level II
Periprocedural antibiotics for intubation should be administered to reduce the incidence of pneumonia. However,
it does not change length of stay or mortality. Early tracheostomy should be performed to reduce mechanical ventilation days. However, it does not alter mortality or the rate of nosocomial pneumonia.
C. Level III
Routine ventricular catheter exchange or prophylactic antibiotic use for ventricular catheter placement is not
recommended to reduce infection. Early extubation in qualified patients can be done without increased risk of pneumonia.
C. Level III
Graduated compression stockings or intermittent pneumatic compression (IPC) stockings are recommended,
unless lower extremity injuries prevent their use. Use should be continued until patients are ambulatory. Low molecular weight heparin (LMWH) or low dose unfractionated heparin should be used in combination with mechanical prophylaxis. However, there is an increased risk for expansion of intracranial hemorrhage.
B. Level II
Intracranial pressure (ICP) should be monitored in all salvageable patients with a severe traumatic brain injury (TBI; Glasgow Coma Scale [GCS] score of 38 after resuscitation) and an abnormal computed tomography (CT) scan. An abnormal CT scan of the head is one that reveals
hematomas, contusions, swelling, herniation, or compressed basal cisterns.
C. Level III
ICP monitoring is indicated in patients with severe TBI with a normal CT scan if two or more of the following features are noted at admission:
age over 40 years,
unilateral or bilateral motor posturing, or
systolic blood pressure (BP) 90 mm Hg.
B. Level II
Treatment should be initiated with intracranial pressure (ICP) thresholds above 20 mm Hg.
C. Level III
A combination of ICP values, and clinical and brain CT findings, should be used to determine the need for treatment.
B. Level II
Aggressive attempts to maintain cerebral perfusion pressure (CPP) above 70 mm Hg with fluids and pressors should be avoided because of the risk of adult respiratory distress syndrome (ARDS).
C. Level III
CPP of <50 mm Hg should be avoided.
C. Level III
Jugular venous saturation (50%) or brain tissue oxygen tension (15 mm Hg) are treatment thresholds. Jugular venous saturation or brain tissue oxygen monitoring measure cerebral oxygenation.
B. Level II
Prophylactic administration of barbiturates to induce burst suppression EEG is not recommended.
High-dose barbiturate administration is recommended to control elevated ICP refractory to maximum standard medical and surgical treatment. Hemodynamic stability is essential before and during barbiturate therapy.
Propofol is recommended for the control of ICP, but not for improvement in mortality or 6 month outcome. High-dose propofol can produce significant morbidity.
B. Level II
Patients should be fed to attain full caloric replacement by day 7 post-injury.
B. Level II
Prophylactic use of phenytoin or valproate is not recommended for preventing late posttraumatic seizures (PTS).
Anticonvulsants are indicated to decrease the incidence of early PTS (within 7 days of injury). However, early PTS is not associated with worse outcomes.
B. Level II
Prophylactic hyperventilation (PaCO2 of 25 mm Hg or less) is not recommended.
C. Level III
Hyperventilation is recommended as a temporizing measure for the reduction of elevated intracranial pressure (ICP).
Hyperventilation should be avoided during the first 24 hours after injury when cerebral blood flow (CBF) is often
critically reduced.
If hyperventilation is used, jugular venous oxygen saturation (SjO
2) or brain tissue oxygen tension (PbrO2) measurements are recommended to monitor oxygen delivery.
A. Level I
The use of steroids is not recommended for improving outcome or reducing intracranial pressure (ICP). In patients with moderate or severe traumatic brain injury (TBI), high-dose methylprednisolone is associated with increased mortality and is contraindicated.
Guidelines for Management of TBI (Brain Trauma Taskforce, braintrauma.org)
Not following these guidelines led to poorer outcome (Acta Neurochir
1999;141(11):1203-8)
systolic blood pressure (SBP) > 90 at all times and preferably a SBP = 120 mmHg, MAP > 85 mm Hg, ICP < 20 mm Hg, CPP > 60 mmHG, O2 saturation > 90%, and PaO2 > 60 mm Hg
Any episode of hypotension or hypoxia dramatically increases head injury mortaility (Archives of Surg 2001:136;1118-1123)
A single episode of hypotension (BP <90 mmHg) or hypoxia (PaO2 <60 mmHg) during the initial resuscitation was associated with a 150% increase in morbidity and mortality--Chestnut RM. J Trauma 1993; 34:216-222.
New study shows that hypotensive increases the mortality dramatically, but not more than non-head injured trauma patients (J Trauma 2005;59:830-835)
brain hits opposite wall first. Air bubble in soda bottle (Neurocritical Care 2004;1:384)
Widespread structural failure of axons
motor component of GCS is most important as well as the ability to obey simple one-step commands
Early Prognostic Indicators:
Patient Age >60 (but the older you are, the worse you do)
Motor of GCS
Pupillary Size/Reactivity
in one study, 10% of patients presumed to have no chance for recovery had only
moderate to no neuro disabilities at 12 months.
Get article J trauam 1996;41:99
If a bullet has penetrated the brainstem or basal ganglia, nobody survives
Somatosensory evoked potentials are best predictors (Inten Care Med 2005;31:765)
Predictive ability of the GCS score (J Neurosci Nursing 2007;39(2):68)
Age, GCS, and pupillary reaction are the most predictive
Motor Score is most important part of the gcs
ICP Monitor, either ventriculostomy or bolt (parenchymal strain gauge) if abnormal CT or normal CT c 2 of 3: SBP<90, Age>40, posturing
CPP=MAP-ICP
Raising CPP
Conceptually a decreased CPP causes vasodilation resulting in higher ICPS,
allegedly raising CPP will break this cycle.
Lund Therapy on the other hand: emphasizes reduction of microvascular pressures
to minimize edema. Maintain normal or high colloid osmotic pressure, reduce
systemic blood pressures, and vasoconstrict precapillary vasculature.
Use CPP of 60 as per most current recs from BTF
Norepinephrine but not dopamine was able to increase CBF in patients with head injury (Crit Care Med 2004;32(4):1049)
the paper for optimization of fluid balance in head injury (Crit Care Med 2002;32(4):739) better outcome if ICP<25,MAP>70,CPP>60, and fluid balance toward positive >-594. latter was indepenendent of the other three.
two studies on blood flow and tissue oxygenation in brain using norepi
(Perfusion/O2=Inten Care Med 2004;30(5):791) (CPP--Crit Care Med 2004;32(4):1049)
and (
Intensive Care Med. 2004 Jan;30(1):45-50.Pharmacokinetics and pharmacodynamics
of dopamine and norepinephrine in critically ill head-injured patients.)
CPP and Hypoxia (Crit Care 2005;9:R670)
risk of hypoxia high at CPP<60. If >70, then it is much less
Review (Crit Care Med 2005;33(6):1392)
Figure.
Addenbrooke's Neurosciences Critical Care Unit Intracranial Pressure (ICP)
Management AlgorithmCVP, central venous pressure; ICP, intracranial pressure,
Sjo2, jugular oxygen saturation; NCCU, neurosciences critical care unit; CPP,
cerebral perfusion pressure; Pto 2 , tissue oximetry; LPR, lactate/pyruvate
ratio; SOL, space-occupying lesion; CSF, cerebrospinal fluid; Rx, treatment;
PAC, pulmonary artery catheter; Spo2 , arterial oxyhemoglobin saturation; Temp,
temperature; iv, intravenously; NG, nasogastrically; EVD, external ventricular
drainage; EEG, electroencephalogram; THAM, Tris(hydroxymethyl)-aminomethane;
re-CT, repeat computed tomography.
From: Nortje: Crit Care Med, Volume 36(1).January 2008.273-281
ICP>20
When managing CPP one needs to use the blood pressure seen by the
brain, not the heart. This is a matter of physics, not opinion (or as
Marisa Tomei says in My Cousin Vinny, it's a fact). While it is of
course possible to measure the height of the column of blood above the
heart, convert it to mmHg, and subtract it from the MAP measured at
the heart, I think it is vastly more efficient and accurate to zero
the transducer at the ear and tape it next to the patient's head, so
that it rises and falls with the patient. On this point your mileage
can not vary. (Bleck)
keep head 30 to 45 degrees
Treat any fever aggressively

Ensure CO2 35-40
Review of hyperventilation (Chest 2005;127(5):1812)
hypervent more than 24 hours is almost certainly not helpful and most likely deleterious
Hyperventilation stops working after 12-24 hours and brain resets at new CO2 (Chest 2005;127(5):1812)
comatose trauma patients while waiting for OR should get 1.2-1.4 G/kg of mannitol (wide open) followed by 14 cc/kg of NS wide open, though HTS is probably better. (Cochrane 2005 Mannitol for acute traumatic brain injury)
Ulttra-early high-dose (1.4 G/kg) mannitol administration (given rapidly) in the
emergency room is the first known treatment strategy significantly to reverse
recent clinical signs of impending brain death, and also to contribute directly
to improved long-term clinical outcomes for these patients who have previously
been considered unsalvageable. (J Neurosurg. 2004 Mar;100(3):376-83)
for ICP elevations, use 0.25-1.0 G/kg. Bolus at rate not to exceed 0.1 g/kg/min
replace urinary losses of fluid
works by diluting blood and decreasing viscosity
effects are rheologic (a science dealing with the deformation and flow of
matter). Also may increase cardiac output. Can increase CBF even when there is no effect on ICP
increased blood flow causes reactive vasoconstriction which decreases ICP
But the osmotic diuresis can lead to hypotension and accumulation of mannitol in CNS can lead to a rebound effect
Maximal effects are seen at 20-60 minutes, lasts 6 hours
administer over 10-15 minutes to avoid hypotension
most effective in lowering ICP when CPP is below 70
hypotension is a contraindication to mannitol use
Up to Osm of 320-330
normal osmole gap is more indicative that it is safe to give the next dose of mannitol than serum osmalality (Crit Care Med 2004 32, p.986)
plasma volume expander duration of 90 minutes to ~6 hours
also may be free radical scavenger and may inhibit apoptosis
3% 250 cc bolus over 10-15 minutes (~4 cc/kg)
Can get hyperchloremic acidosis (add amp of bicarb to bag). Keep Na<160 and Osm<330 (Some would say 360 for hypertonic saline)
7.5% in dextran is half NaCl and half NaAcetate (~2 cc/kg)
23.4% (4-molar saline (4000 mEq Na+/litre))
It is impossible to give a lot of it by mistake (like you could perhaps
with 500 ml bags of 1.8% or 3% saline) since it comes in 20 or 30 ml ampoules
(can be given 30 cc at a time)
Use 20-40 ml of it as a slow IV push (2 minutes) to lower
worrisome ICP (40 mmHg), and often run small volumes of it (2-5 ml/hr)
by continuous (syringe in "Gemini" pump) infusion to maintain a hyperosmolar state during enteral
nutrition. Some patients need a little
furosemide every now and then to
prevent progressive ECF expansion with
this therapy, others (probably under the influence of the CPP-driven MAP
of 90-100 or so) just diurese both salt and water and do not develop ECF
expansion despite large (600+ mmol/day) intakes of sodium.
In one protocol, 3% half acetate and half chloride was effective for TBI (Crit Care Med 1998;26(3):440)
Head to Head Mannitol and Hypertonic (Crit Care
2005;9:R530-40)
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5
versus mannitol 15% in the treatment of increased intracranial
pressure in neurosurgical patients a randomized clinical trial
9. Vialet R, Albanese J, Thomachot L, et al: Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:16831687
12. Francony G, Fauvage B, Falcon D, et al: Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36:795800
13. Battison C, Andrews PJ, Graham C, et al: Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33:196202, discussion 257198
14. Berger S, Schurer L, Hartl R, et al: 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir Suppl (Wien) 1994; 60:494498
15. Freshman SP, Battistella FD, Matteucci M, et al: Hypertonic saline (7.5%) versus mannitol: A comparison for treatment of acute head injuries. J Trauma 1993; 35:344348
16. Harutjunyan L, Holz C, Rieger A, et al: Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients: A randomized clinical trial [ISRCTN62699180]. Crit Care 2005; 9:R530R540
17. Mirski AM, Denchev ID, Schnitzer SM, et al: Comparison between hypertonic saline and mannitol in the reduction of elevated intracranial pressure in a rodent model of acute cerebral injury. J Neurosurg Anesthesiol 2000; 12:334344
18. Zornow MH, Oh YS, Scheller MS: A comparison of the cerebral and haemodynamic effects of mannitol and hypertonic saline in an animal model of brain injury. Acta Neurochir Suppl (Wien) 1990; 51:324325
onset 15-30 minutes, lasts 1-3 hours
permeability of BBB to sodium is low, so sets up osmotic gradient. The reflection coefficient of HTS is higher than mannitol. Increases MAP and CO. Restores neuronal membrane potential and modulates inflammatory response by reducing adhesion of leukocytes.
Review article (Anesth Analg 2006;102:1836)
when calculating osmal for brain effects, include glucose, but not the BUN
Excellent Editorial (Crit Care Med 2006;34(12):3037)
Study vs. placebo in SAH with ICP (Crit Care Med 2006;34(12):2912)
2cc/kg over 30 min of 7.5% in 6% hydroxyethyl starch 200/0.5 solution
Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain.(Crit Care Med. 1998 Mar;26(3):440-6.)
Use of 3% vs. mannitol for brain relaxation in cranis; same effectiveness, less diuresis with 3% (Anesth 2007;107:697)
IVC if not already placed
has side effects of hypotension and cv depression
10 mg/kg loading dose over 30 minutes then 5 mg/kg/h over next 3 hours.
pts become anergic and poikilothermic so signs of infection such as fever, wbc,
and tachycardia may all be suppressed
Causes hypokalemia (Intensive Care Med. 2002 Sep;28(9):1357-60.)
The reason hypokalemia occurs in barbiturate intoxication (or barbiturate-induced coma) is the same as it is for hypokalemia in moderate hypothermia; barbiturates poison the Na++/K+ pump resulting in translocation of sodium and chloride, and transiently, K+, in response to the Gibbs-Donan effect.
Use thiopental (5-10 mg/kg then 3-5 mg/kg/hr) or pentobarbital (10 mg/kg over 30 minutes then 5 mg/kg every hour x 3 doses then 1-2 mg/kg/hr) as they have shorter duration of action
if ICP is persistently above 35 during the first 24 hours
after decompression has a 100% mortality
it should extend to the floor of the middle fossa
cranioplasty should be performed within 1 to 3 months to prevent the "syndrome
of the trephined"
ICP and IAP are correlated (Inten Care Med 2005;31:1577)
THAM may lower ICP as well
GHB may be better than barbs
scans obtained within 3-6 hours of injury may not indicate final lesion size
a scheduled scan 12-24 hours post-injury in severe tbi seems warranted
ICP monitors do not require proph abx other than one dose 30 minutes prior to
placement
pts need 1 week of dilantin
ICP treatment
treat normal patients at 20, treat s/p crani pts at 15
Ways its been described:
Antihypertensive and intracranial volume-targeted therapy
Physiological volume regulation of the intracranial compartments
Central premise:
Impaired autoregulation and blood brain barrier occur in the injured brain
This makes MAP and cerebral capillary hydrostatic pressure driving force behind cerebral edema, and therefore ICP
Furthermore, supporting the CPP with pressors can promote more cerebral edema
Therefore, a good CO with normotension and mild vasoconstriction of precapillary cerebral vessels decreases ICP
The volume-targeted Lund Strategy has several components
Reduction of stress response and cerebral energy metabolism (low dose pentothal, sedation)
Reduction of capillary hydrostatic pressure with systemic antihypertensives (metoprolol and clonidine)
Reduction of capillary hydrostatic pressure with precapillary vasoconstrictors (low-dose pentathol & ergotamine)
Maintenance of colloid osmotic pressure and control of fluid balance
Reduction of cerebral blood volume
What it looks like
Euvolemia to Hypervolemia
Normotension using beta-blockers (metoprolol) and alpha-agonists (clonidine)
Low dose pentothal and dihydroergotamine
CPP typically near traditional limits, but lower CPP tolerated in preference of antihypertensive therapy
ICP effectively kept <20 most of the time
Outcomes
Efficacy of the protocol has been evaluated in experimental and clinical studies
Surrogate physiological/biochemical improvements (lactate/pyruvate ratio in the penumbra zone by microdialysis)
Non-randomized/non-controlled studies suggest significant mortality benefit
Subjective clinical experiences favorable
full description and review (Inten Care Med 2006;32:1475)
should be pvO2 > 20
Immediate Surgery
Midline shift>5mm or mass effect
Large or enlarging hematoma
Depressed skull fracture
Posterior fossa mass lesion
Open wound
LICOX
Review Article (Neurocritical Care 2004;1:392)
Hyperventilation adversely affects PbtO2 (Br J Neurosurg 2003;17(4):340-346)
needs 60-90 minutes run in time to equilibrate
Better Review(Curr Opin Crit Care 2002;8:115-120
Hyperoxia causes cerebral vasoconstriction (Curr Opin Crit Care 2004;10:105
In dogs, better neuro outcome when 21% O2 used in brain injury than 100% (Stroke 1998;29:1679)
Review article summarizing some weak human studies showing that cerebral blood flow decreases with hyperoxia (>133 mmHg) (Br J Anaeth 2003;90:774)
Increased fiO2 changed PbO2 but also jug venous saturation (Anesth Analg 2003;97:851)
Study of waht PbO2 is actually measuring: CBF and difference between Art and venous blood, since it is just a clark electrode, it would make sense that this value rises when you turn up the fiO2 but this does not translate into better O2 delivery (Crit Care Med 2008;36:1917)
transcranial dopplers
PET
Xenon CT Scanning
If TCD has been calibrated to a quantitative measure of CBF, it can relaibly
track changes in CBF
can pick up low flow in the initial 24 horus and vasospasm several days
post-injury
hyperventilation works by adjustment of CSF pH in order to cause
vasoconstriction.
Carbonic anhydrase activity in the choroid plexus will adjust to this new pH and
eliminate the vasconstriction.
Within 4 to 6 hours, there is either a normalization of arteriolar vessel
caliber or actually a hyperemia resulting in elevated ICPs. Keep CO2 at 35
keep crit between 30-35 to maximize oxygen delivery but minimize decreased blood flow due to viscosity
for 1st week. Dilantin may cause drug fever.
Dilantin
Keep on for the first week
Free dilantin should be 1-2
feed glutamine containing immune diet for 5-10 days if GCS<8
Temperature
Must manage aggressively any increased temp
use cooling blanket. Wrap hands and feet to prevent shivering. 24 C was just as effective as 7 C and was assoc with less shivering (Crit Care Med 2005;33(7):1672)
Lovenox
Hold for 72 hours post-injury, post change in status, or post procedure
Uncal-uncus of temporal lobe forced against tentorium cerebelli. CN III compressed, ipsilateral dilated pupil
Cerebellotonsilar-tonsils through foramen magnum, bilat pinpoint
Upwards transtentorial-pontine compression, Bilat pinpoint
usually seen in Subarachnoid Hemorrhage (Inten Care Med 2002;28:1012)
Electric Disturbances
due to stimulation of posterior hypothalamus
problems are tachyarrhythmias and signs of ischemia
t-wave abnormalities are usually benign
ventricular hypokinesis is more rare but can be fatal
Neurogenic Pulmonary Edema
believed to be due to catecholamine hypersecretion
Article of Systemic Complications after Head Inj (Anaesthesia 2007;62:474)
any severe tbi (not just aSAH) can cause sympathetic surge which can cause direct injury of the myocardium
Neurogenic pulmonary edema can occur up to 14 days after the original TBI. catecholamine storm is implicated.
intense pulmonary vasoconstriction; increased intravascular hydrostatic pressure; and transudation of plasma fluid into extravascular space
these cause direct endothelial injuries
O:In patients without ICP monitors the indications for mannitol are signs of
transtentorial herniation or progressive neurological deterioration. Avoid
hypovolemia with fluid replacement. Serum osmolality should be < 320 mOsm to
prevent renal failure. Boluses may be more effective than continuous infusion.
The use of barbiturates in the control of intracranial hypertension Guidelines
G: High-dose barbiturates may be tried in hemodynamically stable salvageable
patients with intracranial hypertension refractory to therapy (both medical and
surgical).
G: Replace 140% of resting metabolism caloric expenditure in non-paralyzed
patients (100% in paralyzed patients) using enteral or parenteral formulas with
at least 15% protein by the 7th day.
O: Most preferable option is jejunal feeding by gastrojejunostomy.
S: Prophylactic use of anticonvulsants is not recommended for late
post-traumatic seizures.
O: Anticonvulsants may be used to stop early post-traumatic seizures in patients
at high risk for seizures following head injury. Note that phenytoin and
carbemazapine have been shown to be effective stopping early post-traumatic
seizures but no outcome benefit has been demonstrated.
Reduced mortality and hematoma size if given within four hours of intracerebral hemorrhage placebo RCT ARR 11% 30 day mortality(NEJM 2005;352:777-85)
Hyponatremia
either CSW or SIADH
key differentiation is hypovolemia.
treatment
oral salt- 3-4 g po/ng tid
hypertonic saline 25 to 75 cc/hr of 3%
fludrocortisone 0.1 to 0.3 mg/day is typical dose. has side effects of hypokalemia, htn, and possibly chf
Urea oral 30 g bid or tid for one day or iv 80 g as 30% solution over 6 hours
(40 g in 150 cc NS as a IV drip, infused over 8 hours)
SIADH can also be treated with Lasix
Demeclocycline abx which induced reversible DI. 300 mg 2-4 times per day. May
take 3-4 days in order to see effects.
Hypernatremia is DI
polyuria over over 200 cc/hr for greater than three hours with a urine SG <1.005
with a rising sodium
Treatment
DDAVP .5 to 2 mcg sc or iv q 8-12
or vasopressin 1-3 units per hour
Consider Diabetes Insipidus
vasopressin drip
Brain Trauma can be the source of hypotension (J Trauma 2003;55:1065)
Our approach is to measure the urine osmolality and make the fluid coming in at least as hypertonic as the urine coming out (no, this is not the man in white at the start of Catch-22). If the patient is getting tube feeding, then you can add salt to the feeds as an alternative to hypertonic saline. Normal saline is not going to raise the serum osmolality, but the latter won't fall as fast if you give normal saline than if you give 5% dextrose. The patient may get better before the osmolality falls significantly, so you may get by with normal saline not because it is the correct thing to do but because the hypothalamus was able to cause free water excretion. Tom Bleck
csw most often from lesions to the hypothalamus or forebrain
loss of weight is suggestive as pt is fluid depleted
- low pulmonary capillary wedge presure (PCWP < 8 mm Hg) or low central venous pressure (CVP < 6 mm Hg) if invasive measurement of volume status available
- urine Na+ markedly elevated (variable in SIADH) & urine volume increased in CSW
- high BUN and Hematocrit supports CSW (prerenal azotemia and hemoconcentration)
- elevated serum K+ not usually seen in SIADH and implies CSW
- serum uric acid often increased in volume depletion (CSW) while low in SIADH
- may add oral salt or hypertonic saline to ensure positive sodium balance
- amount of sodium required to correct deficit obtained by multiplying deficit in serum sodium by total body water (50-60% of ideal body weight) and correcting at no more than 1 mmol/L per hour (risk of precipitating central pontine myelinolysis with rapid correction)
- may prevent further salt loss with volume expansion by using mineralocorticoid fludrocortisone which enhances sodium reabsorption by acting directly on tubule (but can cause hypokalemia, fluid overload and hypertension)
- very effective in preventing hyponatremia from SAH (ARR of 25%, NNT 4) and reduced need for dobutamine to augment cerebral perfusion
in post hoc analysis of SAFE, albumin was assoc. with higher mortality (NEJM 2007;357:874)
prospective study shows it's there more than we think (Crit Care Med 2005;33:2358)
THE RELATIONSHIP OF INTRAOCULAR
PRESSURE TO INTRACRANIAL PRESSURE
Ann Emerg Med 43(5):585, May 2004
METHODS: In this prospective study, from Ohio State University, the
correlation between IOP and ICP was evaluated in 27 ICU patients without
known glaucoma who were undergoing invasive monitoring of ICP due to a
variety of conditions that included intracranial hemorrhage, ischemic
stroke, trauma, tumor or shunt malfunction. A total of 76 measurements of
IOP with a handheld Tono-Pen XL applanation tonometer were performed
simultaneously with invasive ICP measurement.
RESULTS: At a cut-off of 20 mmHg as an indicator of pressure elevation, the
sensitivity and specificity of IOP measurement for elevated ICP were each
100%. All patients with elevated ICP had increased IOP, and all with normal
IOP had normal ICP. Although there was a high overall correlation between
IOP and ICP (r=0.83), differences between the two parameters were increased
with increasing pressure levels and the potential difference between the two
techniques at higher ICP ranges could be as great as 40cm H2O.
CONCLUSIONS: Results from this pilot study require verification, but suggest
that noninvasive measurement of IOP might prove to be a useful indicator of
elevated ICP. 19 references (hiestand-1@medctr.osu.edu)
Signs on Herniation
Unilateral or bilateral unreactive, dilated pupil
Extensor posturing (decerebrate)
A sharp decline in GCS
decerebrate posturing=brainstem dysfunction
decorticate posturing=brainstem functioning
Cochrane Database Syst Rev. 2005 Oct 19;(4):CD001049. Related Articles,
Links
Update of:
Cochrane Database Syst Rev. 2003;(2):CD001049.
Mannitol for acute traumatic brain injury.
Wakai A, Roberts I, Schierhout G.
St Vincent's Hospital, Department of Emergency Medicine, Dublin 4, Ireland.
wakai@indigo.ie
BACKGROUND: Mannitol is sometimes effective in reversing acute brain
swelling, but its effectiveness in the ongoing management of severe head
injury remains unclear. There is evidence that, in prolonged dosage,
mannitol may pass from the blood into the brain, where it might cause
increased intracranial pressure. OBJECTIVES: To assess the effects of
different mannitol therapy regimens, of mannitol compared to other
intracranial pressure (ICP) lowering agents, and to quantify the
effectiveness of mannitol administration given at other stages following
acute traumatic brain injury. SEARCH STRATEGY: The review drew on the search
strategy for the Injuries Group as a whole. We checked reference lists of
trials and review articles, and contacted authors of trials. The searches
were last updated in April 2005. SELECTION CRITERIA: Randomised trials of
mannitol, in patients with acute traumatic brain injury of any severity. The
comparison group could be placebo-controlled, no drug, different dose, or
different drug. We excluded cross-over trials, and trials where the
intervention was started more than eight weeks after injury. DATA COLLECTION
AND ANALYSIS: The reviewers independently rated quality of allocation
concealment and extracted the data. Relative risks (RR) and 95% confidence
intervals (CI) were calculated for each trial on an intention to treat
basis. MAIN RESULTS: In the acute management of comatose patients with
severe head injury, the administration of high-dose mannitol resulted in
reduced mortality (RR= 0.56; 95% CI 0.39 to 0.79) and reduced death and
severe disability (RR= 0.58; 95% CI 0.47 to 0.72) when compared with
conventional-dose mannitol. One trial compared ICP-directed therapy to
'standard care' (RR for death= 0.83; 95% CI 0.47 to 1.46). One trial
compared mannitol to pentobarbital (RR for death= 0.85; 95% CI 0.52 to
1.38). One trial compared mannitol to hypertonic saline (RR for death= 1.25;
95% CI 0.47 to 3.33). One trial tested the effectiveness of pre-hospital
administration of mannitol against placebo (RR for death= 1.75; 95% CI 0.48
to 6.38). AUTHORS' CONCLUSIONS: High-dose mannitol may be preferable to
conventional-dose mannitol in the acute management of comatose patients with
severe head injury. Mannitol therapy for raised ICP may have a beneficial
effect on mortality when compared to pentobarbital treatment, but may have a
detrimental effect on mortality when compared to hypertonic saline. ICP-directed
treatment shows a small beneficial effect compared to treatment directed by
neurological signs and physiological indicators. There are insufficient data
on the effectiveness of pre-hospital administration of mannitol.
Vialet 2003 compared mannitol to hypertonic saline. Eligible
patients were those with severe head injury (GCS8) who required
intravenous infusions of an osmotic agent to treat episodes
of intracranial hypertension resistant to standard therapy (cerebrospinal
uid drainage, volume expansion and/or inotropic support,
hyperventilation). The mannitol group received 20% mannitol
solution. The hypertonic saline group received 7.5% hypertonic
saline. The infused volume was the same for both solutions:
2 ml/kg body weight in 20 minutes. The aim was to decrease ICP
to .25 mm Hg or to increase CPP to .70 mm Hg. In case the
rst infusion failed, the patient received a second infusion within
ten minutes after the end of the rst infusion. Treatment failure
was de ned as the inability to decrease ICP to .35 mm Hg or to
increase CPP to .70mmHg with two consecutive infusions of the
selected osmotic solution. In that case, the protocol was stopped,
and patients were followed up for mortality or 90-day neurologic
status. Because 20% mannitol can crystallize at ambient temperature,
injections could not be performed in a blinded manner.
Twenty patients were randomised, ten to each group. Outcome
was assessed at 90 days using the Glasgow Outcome Scale administered
by a practitioner who was blind to acute patient care.
One trial compared mannitol to hypertonic saline (Vialet 2003).
This trial was randomised and single blind. Only patients with
head injury and persistent coma who required osmotherapy to treat
episodes of intracranial hypertension resistant to standard therapy
were included. For mannitol compared to hypertonic saline in
the treatment of refractory intracranial hypertension episodes in
comatose patients with severe head injury, the RR for death was
1.25 (95% CI 0.47 to 3.33).
Brain oedema peaks at 35 days after hemispheric strokes. Patients with brainstem or cerebellar strokes might develop substantial oedema in the first couple of days. Few patients develop enough oedema to warrant medical intervention.193 Patients requiring intervention usually have large multilobar infarctions.194, 195, 196 and 197 Cerebellar infarctions with oedema can obstruct flow of cerebrospinal fluid, leading to acute hydrocephalus and increased intracranial pressure.192
Article content is available to ACEP members only; if
you are an ACEP member, but do not have a Web account, please take a moment
to
create one now.
![]()
SAN FRANCISCO (EGMN)-Osmotic therapy using hypertonic saline reduced intracranial hypertension in 24 patients with traumatic brain injury while improving cerebral perfusion pressure and brain tissue oxygen levels, Dr. Archie Defillo reported.
The treatments caused no complications in these patients. Judging from the findings of this small series of patients, hypertonic saline appears to be a safe alternative to mannitol for osmotic therapy to control intracranial pressure after traumatic head injury, Dr. Defillo said at the annual meeting of the American Association of Neurological Surgeons.
With his associates, Dr. Defillo reviewed records on head trauma patients with intracranial pressure greater than 20 mm Hg for longer than 20 minutes in the absence of response to nociceptive stimuli, and who had not received other osmotic agents after traumatic brain injury. The 24 patients were infused with 30 ml of 23.4% sodium chloride solution over a 15-minute period. Patients with low hemoglobin levels received blood transfusion to maintain a constant oxygen delivery.
The hypertonic saline decreased intracranial pressure absolute values by a mean of 35% from baseline, consisting of a 10 mm Hg decrease in the first hour and an 8 mm Hg decrease sustained in hours 2-6, said Dr. Defillo of Hennepin County Medical Center, Minneapolis.
"Six millimeters of mercury can be the difference between profound ischemia and normal brain tissue oxygen values," he noted.
Cerebral perfusion pressures and brain tissue oxygen levels improved over the course of osmotic therapy. Cerebral perfusion pressures increased by a mean 14% (8 mm Hg/hr). Brain tissue oxygen levels showed a steady, linear increase ranging from 3% after the first hour of hypertonic saline to 25% by 6 hours after infusion.
Mean arterial pressures remained stable, with the only significant change being a 4 mm Hg decrease 6 hours after infusion.
The greatest benefit from hypertonic saline osmotic therapy was seen in patients with higher intracranial pressure or lower cerebral perfusion pressure.
Hypertonic saline does not cause the rebound effect that can be seen with mannitol, Dr. Defillo noted. Repeat doses of hypertonic saline were not associated with fluid depletion, hypovolemia, or hypertension.
The next research step should be a prospective trial comparing hypertonic saline with mannitol for osmotic therapy in head trauma patients, commentators suggested.
Traumatic brain injury can lead to increased intracranial pressure due to brain edema, blood clots, subdural hematomas, or other intracerebral hemorrhages. The mainstay of nonsurgical management is osmotic therapy.
| Copyright 2006 Elsevier Global Medical News. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. |
| Hypertonic Saline
a Viable Treatment for Controlling Intracranial Pressure in Patients
with Traumatic Brain Injury Contact: Betsy van Die |
|
(847) 378-0517 or bvd@aans.org EMBARGOED FOR RELEASE ON APRIL 24 SAN FRANCISCO (April 24, 2006) - Controlling intracranial pressure (ICP) is an essential component of effectively treating patients with traumatic brain injury (TBI). TBI patients may develop increased ICP as a result of edema (brain swelling), blood clots, subdural hematomas, or other intracerebral hemorrhages. Because the brain is surrounded by the rigid skull, high ICP can cause compression or squeezing of the softer brain tissue, preventing enough blood from getting to the brain tissue. The result can be damage to brain cells. Even a short period of increased ICP can cause permanent damage. Raised ICP, along with hypotension and hypoxia, can increase the mortality rate in TBI patients by 70 percent. TBI survivors are often left with significant cognitive, behavioral, and speech disabilities, and some patients develop long-term medical complications, such as seizures. Osmotic therapy is the cornerstone of nonsurgical management of ICP. There are theoretical reasons why hypertonic saline (HTS) may be a more effective and safe osmotic agent than mannitol. Neurosurgeons at Hennepin County Medical Center (HCMC) in Minneapolis recently assessed the effectiveness of HTS as a single osmotic intervention for controlling ICP and its effect on cerebral perfusion pressure (CPP) and brain tissue oxygen (PtO2). The results of this study, Hypertonic Saline (HTS) and its Effect on Intracranial Pressure (ICP) and Brain Tissue Oxygen (PtO2), will be presented by Archie Defillo, MD, 4:15 to 4:30 p.m. on Monday, April 24, 2006, during the 74th Annual Meeting of the American Association of Neurological Surgeons in San Francisco. Co-authors are Gaylan L. Rockswold, MD, PhD, Jon Jancik, PharmD, and Sarah B. Rockswold, MD. HTS produces massive movement of water out of edematous swollen cells and into the blood vessels. This movement of water out of the brain can reduce swelling and improve cerebral blood flow. This specific action of HTS is due to its reflection coefficient of 1. The high numbers of particles in the solution pull water from a low-pressure compartment to a higher-pressure one. Compared with another osmotic diuretic such as mannitol, in which the reflection coefficient is 0.9 (allowing some leakage outside the blood vessels), HTS will not leak outside the capillaries in the presence of an intact blood-brain barrier. An analysis of 24 consecutive TBI patients (21 males and 3 females, ages 17-64, mean age: 37.5) admitted to the surgical intensive care unit (SICU) at HCMC was conducted. The use of other medications to control ICP was an exclusion criteria to prevent inaccurate results. Blood pressure (BP), mean arterial pressure (MAP), central venous pressure (CVP), heart rate, temperature, intake and output were monitored hourly. Serum sodium, osmolality, and arterial blood gases were checked every six hours. Hemoglobin levels, blood urea nitrogen (BUN), serum potassium, chloride, magnesium and phosphate levels were checked daily. The goal of the therapy was to maintain an ICP of less than 20 mmHg, a CPP between 55 and 70 mmHg, and PtO2 of 20mmHg or higher. When ICP increased to more than 20 mmHg, 30 milliliters of a 23.4-percent solution of HTS was administered as a single dose or repeated doses to control ICP levels. Hemoglobin levels less than 10 gr/dl were corrected via blood transfusion to maintain a constant oxygen delivery (VDO2). The following results were noted:
"There were no complications as a result of this treatment, so in conclusion, HTS is a viable option for decreasing ICP and improving CPP and PtO2 in TBI patients," said Dr. Defillo. "Studying a larger patient pool would provide an even better assessment of the effectiveness of HTS as a treatment option for TBI," concluded Dr. Defillo. Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 6,800 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the entire nervous system, including the spinal column, spinal cord, brain and peripheral nerves.
# # #
Media Representatives:
If you would like to cover the meeting or interview a neurosurgeon
"either on-site or via telephone" please contact the AANS
Communications Department at |
Arterial carbon dioxide partial pressure (PaCO2)
Because cerebral blood flow and PaCO2 are linearly
related within physiologically relevant ranges, hyperventilation
had become an entrenched practice in cerebral resuscitation.
Reduction in PaCO2 was presumed to augment
cerebral perfusion pressure favourably by reducing the
cross-sectional diameter of the arterial circulation and thus
cerebral blood volume. This would offset increases in
intracranial pressure. Although the logic behind this practice
can be appreciated, in fact, it is contradicted by direct
examination of cerebral well being. The most salient evidence is
derived from TBI investigations. These studies support a
different concept, that being worsening of perfusion by
hyperventilation-induced vasoconstriction in ischaemic tissue.
Indeed, the volume of ischaemic tissue, elegantly assessed with
positron emission tomography in TBI patients, was markedly
increased when moderate hypocapnia was induced.20
This is consistent with the only prospective trial of
hyperventilation on TBI outcome, which observed a decreased
number of patients with good or moderate disability outcomes when
chronic hyperventilation was employed.45
It remains unevaluated whether acute hyperventilation improves
outcome from pending transtentorial herniation or when rapid
surgical decompression of a haematoma (e.g. epidural) is
anticipated. Within the context of focal ischaemic stroke,
clinical trials have found no benefit from induced hypocapnia,17
62 although hyperventilation is sometimes employed in
cases of refractory brain oedema. Use of hyperventilation during
cardiopulmonary resuscitation may serve to increase mean
intrathoracic pressure thereby decreasing perfusion pressure and
is not advocated.5
Consequently, there are few data to support use of
hyperventilation in the context of cerebral resuscitation.
20 Coles JP, Fryer TD, Coleman MR, et al. Hyperventilation following head
injury: effect on ischemic burden and cerebral oxidative metabolism. Crit
Care Med (2007) 35:56878.[CrossRef][ISI][Medline]
21 Drummond JC, McKay LD, Cole DJ, Patel PM. The role of nitric oxide
synthase inhibition in the adverse effects of etomidate in the setting of
focal cerebral ischemia in rats. Anesth Analg (2005)
100:8416.[Abstract/Free Full Text]
22 Elsersy H, Mixco J, Sheng H, Pearlstein RD, Warner DS. Selective gamma-aminobutyric
acid type A receptor antagonism reverses isoflurane ischemic neuroprotection.
Anesthesiology (2006) 105:8190.[CrossRef][ISI][Medline]
23 Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS.
Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term
outcome from severe forebrain ischemia in the rat. Anesthesiology (2004)
100:11606.[CrossRef][ISI][Medline]
24 Fay T. Observations on generalized refrigeration in cases of severe
cerebral trauma. Assoc Res Nerv Ment Dis Proc (1943) 24:61119.
25 Franks NP, Honore E. The TREK K2P channels and their role in general
anaesthesia and neuroprotection. Trends Pharmacol Sci (2004) 25:6018.[CrossRef][Medline]
26 Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased
mortality by normalizing blood glucose after acute ischemic stroke. Acad
Emerg Med (2006) 13:17480.[Abstract/Free Full Text]
27 Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with
mild systemic hypothermia after neonatal encephalopathy: multicentre
randomised trial. Lancet (2005) 365:66370.[ISI][Medline]
28 Goldstein A Jr, Wells BA, Keats AS. Increased tolerance to cerebral
anoxia by pentobarbital. Arch Int Pharmacodyn Ther (1966) 161:13843.[ISI][Medline]
29 Gray JJ, Bickler PE, Fahlman CS, Zhan X, Schuyler JA. Isoflurane
neuroprotection in hypoxic hippocampal slice cultures involves increases in
intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology
(2005) 102:60615.[CrossRef][ISI][Medline]
30 Harada H, Kelly PJ, Cole DJ, Drummond JC, Patel PM. Isoflurane reduces
N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex. Anesth
Analg (1999) 89:14427.[Abstract/Free Full Text]
31 Hellstrom-Westas L, Forsblad K, Sjors G, et al. Earlier Apgar score
increase in severely depressed term infants cared for in Swedish level III
units with 40% oxygen versus 100% oxygen resuscitation strategies: a
population-based register study. Pediatrics (2006)
118:e1798804.[Abstract/Free Full Text]
32 Higgins RD, Raju TN, Perlman J, et al. Hypothermia and perinatal
asphyxia: executive summary of the National Institute of Child Health and
Human Development workshop. J Pediatr (2006) 148:1705.[CrossRef][ISI][Medline]
33 Hoffman WE, Charbel FT, Edelman G, Ausman JI. Thiopental and desflurane
treatment for brain protection. Neurosurgery (1998) 43:10503.[CrossRef][ISI][Medline]
34 Jastremski M, Sutton-Tyrrell K, Vaagenes P, Abramson N, Heiselman D,
Safar P. Glucocorticoid treatment does not improve neurological recovery
following cardiac arrest. Brain Resuscitation Clinical Trial I Study Group.
JAMA (1989) 262:342730.[Abstract]
35 Kaisti KK, Langsjo JW, Aalto S, et al. Effects of sevoflurane, propofol,
and adjunct nitrous oxide on regional cerebral blood flow, oxygen
consumption, and blood volume in humans. Anesthesiology (2003) 99:60313.[CrossRef][ISI][Medline]
36 Kammersgaard LP, Jorgensen HS, Rungby JA, et al. Admission body
temperature predicts long-term mortality after acute stroke: the Copenhagen
Stroke Study. Stroke (2002) 33:175962.[Abstract/Free Full Text]
37 Klinger G, Beyene J, Shah P, Perlman M. Do hyperoxaemia and hypocapnia
add to the risk of brain injury after intrapartum asphyxia? Arch Dis Child
Fetal Neonatal Ed (2005) 90:F4952.[Abstract/Free Full Text]
38 Kurth CD, Priestley M, Watzman HM, McCann J, Golden J. Desflurane confers
neurologic protection for deep hypothermic circulatory arrest in newborn
pigs. Anesthesiology (2001) 95:95964.[CrossRef][ISI][Medline]
39 Lei B, Popp S, Capuano-Waters C, Cottrell JE, Kass IS. Lidocaine
attenuates apoptosis in the ischemic penumbra and reduces infarct size after
transient focal cerebral ischemia in rats. Neuroscience (2004)
125:691701.[CrossRef][ISI][Medline]
40 Leonov Y, Sterz F, Safar P, et al. Mild cerebral hypothermia during and
after cardiac arrest improves neurologic outcome in dogs. J Cereb Blood Flow
Metab (1990) 10:5770.[ISI][Medline]
41 McDonagh DL, Allen IN, Keifer JC, Warner DS. Induction of hypothermia
after intraoperative hypoxic brain insult. Anesth Analg (2006)
103:1801.[Abstract/Free Full Text]
42 Michenfelder J, Terry HJ, Daw E, Uihlein A. Induced hypothermia:
physiologic effects, indications, and techniques. Surg Clin North Am (1965)
45:889.[ISI][Medline]
43 Michenfelder JD, Theye RA. Cerebral protection by thiopental during
hypoxia. Anesthesiology (1973) 39:5107.[ISI][Medline]
44 Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine
during cardiac operations. Ann Thorac Surg (1999)
67:111724.[CrossRef][ISI][Medline]
45 Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged
hyperventilation in patients with severe head injury: a randomized clinical
trial. J Neurosurg (1991) 75:7319.[ISI][Medline]
46 Nasu I, Yokoo N, Takaoka S, et al. The dose-dependent effects of
isoflurane on outcome from severe forebrain ischemia in the rat. Anesth
Analg (2006) 103:4138.[Abstract/Free Full Text]
47 Nellgεrd B, Mackensen GB, Pineda J, Wellons JC 3rd, Pearlstein RD, Warner
DS. Anesthetic effects on cerebral metabolic rate predict histologic outcome
from near-complete forebrain ischemia in the rat. Anesthesiology (2000)
93:4316.[CrossRef][ISI][Medline]
Pupillary constriction is mediated via a parasympathetic pathway, which
requires integrity of the third nerve and its nuclei in the brain, which lie
close to areas involved in consciousness. Third nerve palsy initially causes
mydriasis followed by loss of reactivity to light. Classically, ipsilateral
third nerve palsy has been attributed to compression of the nerve on the
free edge of the tentorium. It may also occur because of kinking of the
nerve over the clivus or buckling of the brainstem as a result of an
increase in supra-tentorial pressure.80 In the presence of unilateral third
nerve palsy, the consensual light reflex (opposite eye constricting in
response to bright light) should still be present. Optic nerve injury (more
common with frontal injuries) will impair both the direct and indirect
responses and may lead to fixed or sluggish pupils, which may display
spontaneous fluctuations (hippus).139
Bilaterally fixed pupils occur in around 2030% of patients with severe head
injury (GCS 8) after resuscitation: 7090% of these patients will have poor
outcome (vegetative or dead) when compared with around 30% with bilaterally
reactive pupils.57 64 66 Unreactive pupils are associated with the presence
of hypotension, lower GCS, and closed basal cisterns on CT.4 14 163 The
underlying pathology influences the prognostic value of unreactive pupils:
patients with epidural haematoma fare better than those with subdural
haematoma.115 116 123 129 Unilaterally unreactive pupils have an outcome
intermediate between bilaterally reactive and unreactive pupils. Pupil
asymmetry is associated with an operable mass lesion in around 30% of
patients.18
Table 7 Marshall CT classification of TBI
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypotension
Hypoxia
Most,19
68
93 but not all90
observational studies in TBI have found an association between
observed early hypoxia [SpO2 < 90% or <7.9
kPa (60 mm Hg)] and poor outcome. The association is not as
strong as for hypotension, and may be less important in children.118
Hypoxia may be a marker of the severity of brain or systemic
injury, or it may be a secondary insult to the at risk brain. It
may also be a surrogate marker for marked hypercapnia, which
would be expected to lower cerebral perfusion pressure. Animal
work suggests that, in rats, the combination of hypoxia and
percussive trauma leads to a small increase in oedema formation
when compared with the percussive trauma alone, presumably because
of the increasing inability of injured cells to maintain ionic
homeostasis.164
1 Acheson MB, Livingston RR, Richardson ML, Stimac GK. High-resolution CT
scanning in the evaluation of cervical spine fractures: comparison with
plain film examinations. Am J Roentgenol (1987) 148:117985.[Abstract/Free
Full Text]
2 Adams JH, Doyle D, Ford I, Gennarelli TA, Graham DI, McLellan DR. Diffuse
axonal injury in head injury: definition, diagnosis and grading.
Histopathology (1989) 15:4959.[ISI][Medline]
3 Alderson P, Roberts I. Corticosteroids in acute traumatic brain injury:
systematic review of randomised controlled trials. Br Med J (1997)
314:18559.[Abstract/Free Full Text]
4 Andrews BT, Levy ML, Pitts LH. Implications of systemic hypotension for
the neurological examination in patients with severe head injury. Surg
Neurol (1987) 28:41922.[CrossRef][ISI][Medline]
5 Arango MF, Mejia-Mantilla JH. Magnesium for acute traumatic brain injury.
Cochrane Database Syst Rev (2006) 4. doi:10.1002/14651858. CD005400.pub2.
6 Balestreri M, Czosnyka M, Chatfield DA, et al. Predictive value of Glasgow
Coma Scale after brain trauma: change in trend over the past ten years. J
Neurol Neurosurg Psychiatry (2004) 75:1612.[Abstract/Free Full Text]
7 Bernard F, Menon DK, Matta BF. Corticosteroids after traumatic brain
injury: new evidence to support their use. Crit Care Med (2006) 34:583.[CrossRef][ISI][Medline]
8 Berne JD, Velmahos GC, El-Tawil Q, et al. Value of complete cervical
helical computed tomographic scanning in identifying cervical spine injury
in the unevaluable blunt trauma patient with multiple injuries: a
prospective study. J Trauma (1999) 47:896902.[ISI][Medline]
9 Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid
resuscitation for hypotensive patients with penetrating torso injuries. N
Engl J Med (1994) 331:11059.[Abstract/Free Full Text]
10 Blumbergs PC, Jones NR, North JB. Diffuse axonal injury in head trauma. J
Neurol Neurosurg Psychiatry (1989) 52:83841.[Abstract]
11 Boto GR, Gomez PA, De La Cruz J, Lobato RD. Severe head injury and the
risk of early death. J Neurol Neurosurg Psychiatry (2006)
77:10549.[Abstract/Free Full Text]
12 Bouma GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral
circulation and metabolism after severe traumatic brain injury: the elusive
role of ischemia. J Neurosurg (1991) 75:68593.[ISI][Medline]
13 Bouma GJ, Muizelaar JP, Stringer WA, Choi SC, Fatouros P, Young HF.
Ultra-early evaluation of regional cerebral blood flow in severely
head-injured patients using xenon-enhanced computerized tomography. J
Neurosurg (1992) 77:3608.[ISI][Medline]
14 Braakman R, Gelpke GJ, Habbema JD, Maas AI, Minderhoud JM. Systematic
selection of prognostic features in patients with severe head injury.
Neurosurgery (1980) 6:36270.[ISI][Medline]
15 Brain Trauma Foundation. Guidelines for Prehospital Management of
Traumatic Brain Injury (2000) New York: Brain Trauma Foundation.
16 Brain Trauma Foundation. Management and Prognosis of Severe Traumatic
Brain Injury (2000) New York: Brain Trauma Foundation.
17 Canavero S, Bonicalzi V, Narcisi P. Safety of magnesium-lidocaine
combination for severe head injury: the Turin lidomag pilot study. Surg
Neurol (2003) 60:1659.[CrossRef][ISI][Medline]
18 Chesnut RM, Gautille T, Blunt BA, Klauber MR, Marshall LE. The localizing
value of asymmetry in pupillary size in severe head injury: relation to
lesion type and location. Neurosurgery (1994) 34:8405.[ISI][Medline]
19 Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain
injury in determining outcome from severe head injury. J Trauma (1993)
34:21622.[ISI][Medline]
20 Chesnut RM, Marshall SB, Piek J, Blunt BA, Klauber MR, Marshall LF. Early
and late systemic hypotension as a frequent and fundamental source of
cerebral ischemia following severe brain injury in the Traumatic Coma Data
Bank. Acta Neurochir Suppl (Wien) (1993) 59:1215.[Medline]
21 Choi SC, Barnes TY, Bullock R, Germanson TA, Marmarou A, Young HF.
Temporal profile of outcomes in severe head injury. J Neurosurg (1994)
81:16973.[ISI][Medline]
22 Choi SC, Narayan RK, Anderson RL, Ward JD. Enhanced specificity of
prognosis in severe head injury. J Neurosurg (1988) 69:3815.[ISI][Medline]
23 Clifton GL, Ziegler MG, Grossman RG. Circulating catecholamines and
sympathetic activity after head injury. Neurosurgery (1981) 8:1014.[ISI][Medline]
24 Cochran A, Scaife ER, Hansen KW, Downey EC. Hyperglycemia and outcomes
from pediatric traumatic brain injury. J Trauma (2003) 55:10358.[ISI][Medline]
25 Cohan P, Wang C, McArthur DL, et al. Acute secondary adrenal
insufficiency after traumatic brain injury: a prospective study. Crit Care
Med (2005) 33:235866.[CrossRef][ISI][Medline]
26 Davis DP, Dunford JV, Ochs M, Park K, Hoyt DB. The use of quantitative
end-tidal capnometry to avoid inadvertent severe hyperventilation in
patients with head injury after paramedic rapid sequence intubation. J
Trauma (2004) 56:80814.[ISI][Medline]
27 Davis DP, Heister R, Poste JC, Hoyt DB, Ochs M, Dunford JV. Ventilation
patterns in patients with severe traumatic brain injury following paramedic
rapid sequence intubation. Neurocrit Care (2005) 2:16571.[CrossRef][ISI][Medline]
28 Davis DP, Idris AH, Sise MJ, et al. Early ventilation and outcome in
patients with moderate to severe traumatic brain injury. Crit Care Med
(2006) 34:12028.[CrossRef][ISI][Medline]
29 Davis DP, Peay J, Sise MJ, et al. The impact of prehospital endotracheal
intubation on outcome in moderate to severe traumatic brain injury. J Trauma
(2005) 58:9339.[ISI][Medline]
30 Davis DP, Serrano JA, Vilke GM, et al. The predictive value of field
versus arrival Glasgow Coma Scale score and TRISS calculations in
moderate-to-severe traumatic brain injury. J Trauma (2006) 60:98590.[ISI][Medline]
31 Davis DP, Stern J, Sise MJ, Hoyt DB. A follow-up analysis of factors
associated with head-injury mortality after paramedic rapid sequence
intubation. J Trauma (2005) 59:48690.[Medline]
32 Demetriades D, Kuncir E, Velmahos GC, Rhee P, Alo K, Chan LS. Outcome and
prognostic factors in head injuries with an admission Glasgow Coma Scale
score of 3. Arch Surg (2004) 139:10668.[Abstract/Free Full Text]
33 DeWitt DS, Jenkins LW, Prough DS. Enhanced vulnerability to secondary
ischemic insults after experimental traumatic brain injury. New Horiz (1995)
3:37683.[Medline]
34 Diringer MN. Is aggressive treatment of hyperglycemia for everyone? Crit
Care Med (2006) 34:9301.[CrossRef][ISI][Medline]
35 Eisenberg HM, Gary HE Jr, Aldrich EF, et al. Initial CT findings in 753
patients with severe head injury. A report from the NIH Traumatic Coma Data
Bank. J Neurosurg (1990) 73:68898.[ISI][Medline]
36 Excellence, National Institute of Clinical. Head Injury Triage,
Assessment, Investigation and Early Management of Head Injury in Infants
Children and Adults. Clinical Guideline 4 (2003) London: NICE.
37 Farin A, Deutsch R, Biegon A, Marshall LF. Sex-related differences in
patients with severe head injury: greater susceptibility to brain swelling
in female patients 50 years of age and younger. J Neurosurg (2003) 98:326.[ISI][Medline]
38 Fearnside MR, Cook RJ, McDougall P, McNeil RJ. The Westmead Head Injury
Project outcome in severe head injury. A comparative analysis of
pre-hospital, clinical and CT variables. Br J Neurosurg (1993) 7:26779.[ISI][Medline]
39 Forsyth RJ, Jayamoni B, Paine TC. Monoaminergic agonists for acute
traumatic brain injury. Cochrane Database Syst Rev (2006) 4.
doi:10.1002/14651858. CD003984.pub2.
40 Gale JL, Dikmen S, Wyler A, Temkin N, McLean A. Head injury in the
Pacific Northwest. Neurosurgery (1983) 12:48791.[ISI][Medline]
41 Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital
pediatric endotracheal intubation on survival and neurological outcome: a
controlled clinical trial. JAMA (2000) 283:78390.[Abstract/Free Full Text]
42 Gennarelli TA, Spielman GM, Langfitt TW, et al. Influence of the type of
intracranial lesion on outcome from severe head injury. J Neurosurg (1982)
56:2632.[ISI][Medline]
43 Gentry LR, Godersky JC, Thompson B, Dunn VD. Prospective comparative
study of intermediate-field MR and CT in the evaluation of closed head
trauma. Am J Roentgenol (1988) 150:67382.[Abstract/Free Full Text]
44 Gill MR, Reiley DG, Green SM. Interrater reliability of Glasgow Coma
Scale scores in the emergency department. Ann Emerg Med (2004) 43:21523.[CrossRef][ISI][Medline]
45 Glass TF, Fabian MJ, Schweitzer JB, Weinberg JA, Proctor KG. The impact
of hypercarbia on the evolution of brain injury in a porcine model of
traumatic brain injury and systemic hemorrhage. J Neurotrauma (2001)
18:5771.[CrossRef][ISI][Medline]
46 Goldstein B, Kelly MM, Bruton D, Cox C. Inflicted versus accidental head
injury in critically injured children. Crit Care Med (1993) 21:132832.[ISI][Medline]
47 Graham DI. The pathology of brain ischaemia and possibilities for
therapeutic intervention. Br J Anaesth (1985) 57:317.[Free Full Text]
48 Graham DI, Ford I, Adams JH, et al. Ischaemic brain damage is still
common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry
(1989) 52:34650.[Abstract]
49 Group ALS. Advanced Paediatric Life Support: the Practical Approach
(2005) London: BMJ Books/Blackwell.
50 Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care
management. Br J Anaesth (2007) 99:3242.[Abstract/Free Full Text]
51 Harders A, Kakarieka A, Braakman R. Traumatic subarachnoid hemorrhage and
its treatment with nimodipine. German tSAH Study Group. J Neurosurg (1996)
85:829.[ISI][Medline]
52 Hare GMT, Kavanagh BP, Mazer CD, et al. Hypercapnia increases cerebral
tissue oxygen tension in anesthetized rats. Can J Anaesth (2003)
50:10618.[Abstract/Free Full Text]
53 Hartl R, Gerber LM, Iacono L, Ni Q, Lyons K, Ghajar J. Direct transport
within an organized state trauma system reduces mortality in patients with
severe traumatic brain injury. J Trauma (2006) 60:12506.[ISI][Medline]
54 Havill JH, Sleigh JW, Davis GM, et al. Observer error and prediction of
outcomegrading of head injury based on computerised tomography. Crit Care
Resusc (2001) 3:158.[Medline]
55 Haydel MJ, Preston CA, Mills TJ, Luber S, Blaudeau E, DeBlieux PM.
Indications for computed tomography in patients with minor head injury. N
Engl J Med (2000) 343:1005.[Abstract/Free Full Text]
56 Healey C, Osler TM, Rogers FB, et al. Improving the Glasgow Coma Scale
score: motor score alone is a better predictor. J Trauma (2003) 54:6718.[ISI][Medline]
57 Heiden JS, Small R, Caton W, Weiss M, Kurze T. Severe head injury.
Clinical assessment and outcome. Phys Ther (1983) 63:194651.[ISI][Medline]
58 Hodgkinson DW, Berry E, Yates DW. Mild head injurya positive approach to
management. Eur J Emerg Med (1994) 1:912.[CrossRef][Medline]
59 Hogan GJ, Mirvis SE, Shanmuganathan K, Scalea TM. Exclusion of unstable
cervical spine injury in obtunded patients with blunt trauma: is MR imaging
needed when multi-detector row CT findings are normal? Radiology (2005)
237:10613.[Abstract/Free Full Text]
60 Holly LT, Kelly DF, Counelis GJ, Blinman T, McArthur DL, Cryer HG.
Cervical spine trauma associated with moderate and severe head injury:
incidence, risk factors, and injury characteristics. J Neurosurg (2002)
96:28591.[ISI][Medline]
61 Hukkelhoven CWPM, Steyerberg EW, Rampen AJJ, et al. Patient age and
outcome following severe traumatic brain injury: an analysis of 5600
patients. J Neurosurg (2003) 99:66673.[ISI][Medline]
62 Iida H, Tachibana S, Kitahara T, Horiike S, Ohwada T, Fujii K.
Association of head trauma with cervical spine injury, spinal cord injury,
or both. J Trauma (1999) 46:4502.[ISI][Medline]
63 Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical
trials for stroke and traumatic brain injury? Lancet Neurol (2002)
1:3836.[CrossRef][ISI][Medline]
64 Injury ESGoNiSH. A multicenter trial of the efficacy of nimodipine on
outcome after severe head injury. J Neurosurg (1994)
80:797804.[ISI][Medline]
65 Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiatry
(1996) 60:3629.[ISI][Medline]
66 Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R.
Predicting outcome in individual patients after severe head injury. Lancet
(1976) 1:10314.[ISI][Medline]
67 Jennett B, Teasdale G, Galbraith S, et al. Severe head injuries in three
countries. J Neurol Neurosurg Psychiatry (1977) 40:2918.[Abstract]
68 Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A. Harbingers of
poor outcome the day after severe brain injury: hypothermia, hypoxia, and
hypoperfusion. J Trauma (2003) 54:3129.[ISI][Medline]
69 Johnstone AJ, Lohlun JC, Miller JD, et al. A comparison of the Glasgow
Coma Scale and the Swedish Reaction Level Scale. Brain Inj (1993)
7:5016.[ISI][Medline]
70 Jones PA, Andrews PJ, Midgley S, et al. Measuring the burden of secondary
insults in head-injured patients during intensive care. J Neurosurg
Anesthesiol (1994) 6:414.[ISI][Medline]
71 Kakarieka A, Braakman R, Schakel EH. Clinical significance of the finding
of subarachnoid blood on CT scan after head injury. Acta Neurochir (Wien)
(1994) 129:15.[CrossRef][Medline]
72 Klauber MR, Barrett-Connor E, Marshall LF, Bowers SA. The epidemiology of
head injury: a prospective study of an entire community-San Diego County,
California, 1978. Am J Epidemiol (1981) 113:5009.[Abstract/Free Full Text]
73 Klauber MR, Marshall LF, Luerssen TG, Frankowski R, Tabaddor K, Eisenberg
HM. Determinants of head injury mortality: importance of the low risk
patient. Neurosurgery (1989) 24:316.[ISI][Medline]
74 Knoller N, Levi L, Shoshan I, et al. Dexanabinol (HU-211) in the
treatment of severe closed head injury: a randomized, placebo-controlled,
phase II clinical trial. Crit Care Med (2002)
30:54854.[CrossRef][ISI][Medline]
75 Kobayashi S, Nakazawa S, Otsuka T. Clinical value of serial computed
tomography with severe head injury. Surg Neurol (1983)
20:259.[CrossRef][ISI][Medline]
76 Kuday C, Uzan M, Hanci M. Statistical analysis of the factors affecting
the outcome of extradural haematomas: 115 cases. Acta Neurochir (Wien)
(1994) 131:2036.[CrossRef][Medline]
77 Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of
early hyperglycemia to mortality in trauma patients. J Trauma (2004)
56:105862.[ISI][Medline]
78 Lam AM, Winn HR, Cullen BF, Sundling N. Hyperglycemia and neurological
outcome in patients with head injury. J Neurosurg (1991)
75:54551.[ISI][Medline]
79 Langham J, Goldfrad C, Teasdale G, Shaw D, Rowan K. Calcium channel
blockers for acute traumatic brain injury. Cochrane Database Syst Rev (2003)
[Update of Cochrane Database Syst Rev. 2000;(2):CD000565; PMID: 10796727],
CD000565.
80 Larner AJ. False localising signs. J Neurol Neurosurg Psychiatry (2003)
74:4158.[Abstract/Free Full Text]
81 Levi L, Guilburd JN, Linn S, Feinsod M. The association between skull
fracture, intracranial pathology and outcome in pediatric head injury. Br J
Neurosurg (1991) 5:61725.[ISI][Medline]
82 Link TM, Schuierer G, Hufendiek A, Horch C, Peters PE. Substantial head
trauma: value of routine CT examination of the cervicocranium. Radiology
(1995) 196:7415.[Abstract]
83 Lobato RD, Rivas JJ, Cordobes F, et al. Acute epidural hematoma: an
analysis of factors influencing the outcome of patients undergoing surgery
in coma. J Neurosurg (1988) 68:4857.[ISI][Medline]
84 Lokkeberg AR, Grimes RM. Assessing the influence of non-treatment
variables in a study of outcome from severe head injuries. J Neurosurg
(1984) 61:25462.[ISI][Medline]
85 Lu J, Marmarou A, Choi S, et al. Mortality from traumatic brain injury.
Acta Neurochir Suppl (2005) 95:2815.[Medline]
86 Luber SD, Brady WJ, Brand A, Young J, Guertler AT, Kefer M. Acute
hypoglycemia masquerading as head trauma: a report of four cases. Am J Emerg
Med (1996) 14:5437.[CrossRef][ISI][Medline]
87 Maas AI, Dearden M, Teasdale GM, et al. EBIC-guidelines for management of
severe head injury in adults. European Brain Injury Consortium. Acta
Neurochir (Wien) (1997) 139:28694.[CrossRef][Medline]
88 Maas AIR, Hukkelhoven CWPM, Marshall LF, Steyerberg EW. Prediction of
outcome in traumatic brain injury with computed tomographic characteristics:
a comparison between the computed tomographic classification and
combinations of computed tomographic predictors. Neurosurgery (2005)
57:117382.[ISI][Medline]
89 Maas AIR, Murray G, Henney H III, et al. Efficacy and safety of
dexanabinol in severe traumatic brain injury: results of a phase III
randomised, placebo-controlled, clinical trial. Lancet Neurol (2006)
5:3845.[CrossRef][ISI][Medline]
90 Manley G, Knudson MM, Morabito D, Damron S, Erickson V, Pitts L.
Hypotension, hypoxia, and head injury: frequency, duration, and
consequences. Arch Surg (2001) 136:111823.[Abstract/Free Full Text]
91 Marion DW, Carlier PM. Problems with initial Glasgow Coma Scale
assessment caused by prehospital treatment of patients with head injuries:
results of a national survey. J Trauma (1994) 36:8995.[ISI][Medline]
92 Marion DW, Darby J, Yonas H. Acute regional cerebral blood flow changes
caused by severe head injuries. J Neurosurg (1991) 74:40714.[ISI][Medline]
93 Marmarou A, Anderson RL, Ward JD. Impact of ICP instability and
hypotension on outcome in patients with severe head trauma. J Neurosurg
(Suppl) (1991) 75:159166.
94 Marshall LF, Gantille T, Klauber MR. The outcome of severe head injury. J
Neurosurg (Suppl) (1991) 75:S2536.
95 Marshall LF, Maas AI, Marshall SB, et al. A multicenter trial on the
efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg
(1998) 89:51925.[ISI][Medline]
96 Marshall LF, Marshall SB, Klauber MR, Clark MV. A new classification of
head injury based on computerised tomography. J Neurosurg (Suppl) (1991)
75:S1420.
97 Massagli TL, Michaud LJ, Rivara FP. Association between injury indices
and outcome after severe traumatic brain injury in children. Arch Phys Med
Rehabil (1996) 77:12532.[CrossRef][ISI][Medline]
98 Maxwell WL, Bullock R, Landholt H, Fujisawa H. Massive astrocytic
swelling in response to extracellular glutamatea possible mechanism for
post-traumatic brain swelling? Acta Neurochir Suppl (Wien) (1994)
60:4657.[Medline]
99 Mendelow AD, Gillingham FJ. Extradural haematoma: effect of delayed
treatment. Br Med J (1979) 2:134.[ISI][Medline]
100 Menegazzi JJ, Davis EA, Sucov AN, Paris PM. Reliability of the Glasgow
Coma Scale when used by emergency physicians and paramedics. J Trauma (1993)
34:468.[ISI][Medline]
101 Miller JD, Sweet RC, Narayan R, Becker DP. Early insults to the injured
brain. JAMA (1978) 240:43942.[Abstract]
102 Wilson M, Montgomery H. Impact of genetic factors on outcome from brain
injury. Br J Anaesth (2007) 99:4348.[Abstract/Free Full Text]
103 Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF.
Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS
19755) in the treatment of severe head injury: results of two-phase III
clinical trials. The Selfotel Investigators. J Neurosurg (1999)
91:73743.[ISI][Medline]
104 Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged
hyperventilation in patients with severe head injury: a randomized clinical
trial. J Neurosurg (1991) 75:7319.[ISI][Medline]
105 Murray GD, Teasdale GM, Braakman R, et al. The European Brain Injury
Consortium survey of head injuries. Acta Neurochir (Wien) (1999)
141:22336.[CrossRef][Medline]
106 Murray JA, Demetriades D, Berne TV, et al. Prehospital intubation in
patients with severe head injury. J Trauma (2000) 49:106570.[ISI][Medline]
107 Nakamura N, Yamaura A, Shigemori M, et al. Final report of the Japan
neurotrauma data bank project 19982001: 1,002 cases of traumatic brain
injury. Neurol Med Chir (Tokyo) (2006) 46:56774.[CrossRef][Medline]
108 Narayan RK, Greenberg RP, Miller JD, et al. Improved confidence of
outcome prediction in severe head injury. A comparative analysis of the
clinical examination, multimodality evoked potentials, CT scanning, and
intracranial pressure. J Neurosurg (1981) 54:75162.[ISI][Medline]
109 Network, Scottish Intercollegiate Guidelines. Early Management of
Patients with a Head Injury (2000) Edinburgh: SIGN.
110 Ng I, Lee KK, Lim JHG, Wong HB, Yan XY. Investigating gender differences
in outcome following severe traumatic brain injury in a predominantly Asian
population. Br J Neurosurg (2006) 20:738.[CrossRef][ISI][Medline]
111 Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood
flow and metabolism in comatose patients with acute head injury.
Relationship to intracranial hypertension. J Neurosurg (1984)
61:24153.[ISI][Medline]
112 Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ.
Specialist neurocritical care and outcome from head injury. Intensive Care
Med (2002) 28:54753.[CrossRef][ISI][Medline]
113 Peek-Asa C, McArthur D, Hovda D, Kraus J. Early predictors of mortality
in penetrating compared with closed brain injury. Brain Inj (2001)
15:80110.[ISI][Medline]
114 Pfenninger E, Ahnefeld FW, Kilian J, Dell U. Behavior of blood gases in
patients with craniocerebral trauma at the accident site and at the time of
admission to the clinic. Anaesthesist (1987) 36:5706.[ISI][Medline]
115 Phonprasert C, Suwanwela C, Hongsaprabhas C, Prichayudh P, O'Charoen S.
Extradural hematoma: analysis of 138 cases. J Trauma (1980)
20:67983.[ISI][Medline]
116 Phuenpathom N, Choomuang M, Ratanalert S. Outcome and outcome prediction
in acute subdural hematoma. Surg Neurol (1993)
40:225.[CrossRef][ISI][Medline]
117 Pietropaoli JA, Rogers FB, Shackford SR, Wald SL, Schmoker JD, Zhuang J.
The deleterious effects of intraoperative hypotension on outcome in patients
with severe head injuries. J Trauma (1992) 33:4037.[ISI][Medline]
118 Pigula FA, Wald SL, Shackford SR, Vane DW. The effect of hypotension and
hypoxia on children with severe head injuries. J Pediatr Surg (1993)
28:3104.[CrossRef][ISI][Medline]
119 Povlishock JT. Traumatically induced axonal injury: pathogenesis and
pathobiological implications. Brain Pathol (1992) 2:112.[ISI][Medline]
120 Ransom GH, Mann FA, Vavilala MS, Haruff R, Rivara FP. Cerebral infarct
in head injury: relationship to child abuse. Child Abuse Negl (2003)
27:38192.[CrossRef][ISI][Medline]
121 Reilly PL. Brain injury: the pathophysiology of the first hours. Talk
and Die revisited. J Clin Neurosci (2001) 8:398403.[CrossRef][ISI][Medline]
122 Reilly PL, Simpson DA, Sprod R, Thomas L. Assessing the conscious level
in infants and young children: a paediatric version of the Glasgow Coma
Scale. Childs Nerv Syst (1988) 4:303.[ISI][Medline]
123 Rivas JJ, Lobato RD, Sarabia R, Cordobes F, Cabrera A, Gomez P.
Extradural hematoma: analysis of factors influencing the courses of 161
patients. Neurosurgery (1988) 23:4451.[ISI][Medline]
124 Roberts I. Aminosteroids for acute traumatic brain injury. Cochrane
Database Syst Rev (1999) 3. doi:10.1002/14651858. CD001527.
125 Roberts I, Smith R, Evans S. Doubts over head injury studies. Br Med J
(2007) 334:2924.[Free Full Text]
126 Roberts I, Yates D, Sandercock P, et al. Effect of intravenous
corticosteroids on death within 14 days in 10008 adults with clinically
significant head injury (MRC CRASH trial): randomised placebo-controlled
trial. Lancet (2004) 364:13218.[CrossRef][ISI][Medline]
127 Rosner MJ, Newsome HH, Becker DP. Mechanical brain injury: the
sympathoadrenal response. J Neurosurg (1984) 61:7686.[ISI][Medline]
128 Rutledge R, Lentz CW, Fakhry S, Hunt J. Appropriate use of the Glasgow
Coma Scale in intubated patients: a linear regression prediction of the
Glasgow verbal score from the Glasgow eye and motor scores. J Trauma (1996)
41:51422.[ISI][Medline]
129 Sakas DE, Bullock MR, Teasdale GM. One-year outcome following craniotomy
for traumatic hematoma in patients with fixed dilated pupils. J Neurosurg
(1995) 82:9615.[ISI][Medline]
130 Sarrafzadeh AS, Peltonen EE, Kaisers U, Kuchler I, Lanksch WR, Unterberg
AW. Secondary insults in severe head injurydo multiply injured patients do
worse? Crit Care Med (2001) 29:111623.[CrossRef][ISI][Medline]
131 Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures
following acute traumatic brain injury. Cochrane Database Syst Rev (2001) 4.
doi:10.1002/14651858. CD000173.
132 Seelig JM, Becker DP, Miller JD, Greenberg RP, Ward JD, Choi SC.
Traumatic acute subdural hematoma: major mortality reduction in comatose
patients treated within four hours. N Engl J Med (1981)
304:15118.[Abstract]
133 Selladurai BM, Jayakumar R, Tan YY, Low HC. Outcome prediction in early
management of severe head injury: an experience in Malaysia. Br J Neurosurg
(1992) 6:54957.[ISI][Medline]
134 Servadei F, Murray GD, Penny K, et al. The value of the worst computed
tomographic scan in clinical studies of moderate and severe head injury.
European Brain Injury Consortium. Neurosurgery (2000)
46:705.[CrossRef][ISI][Medline]
135 Servadei F, Nasi MT, Cremonini AM, Giuliani G, Cenni P, Nanni A.
Importance of a reliable admission Glasgow Coma Scale score for determining
the need for evacuation of posttraumatic subdural hematomas: a prospective
study of 65 patients. J Trauma (1998) 44:86873.[ISI][Medline]
136 Sharples PM, Storey A, Aynsley-Green A, Eyre JA. Causes of fatal
childhood accidents involving head injury in northern region, 197986. Br
Med J (1990) 301:11937.[ISI][Medline]
137 Sheinberg M, Kanter MJ, Robertson CS, Contant CF, Narayan RK, Grossman
RG. Continuous monitoring of jugular venous oxygen saturation in
head-injured patients. J Neurosurg (1992) 76:2127.[ISI][Medline]
138 Shohami E, Novikov M, Bass R. Long-term effect of HU-211, a novel
non-competitive NMDA antagonist, on motor and memory functions after closed
head injury in the rat. Brain Res (1995) 674:5562.[CrossRef][ISI][Medline]
139 Simpson DA. Clinical examination and grading. In: Head Injury:
Pathophysiology and Management of Severe Closed Head InjuryReilly PL,
Bullock MR, eds. (1997) London: Chapman and Hall Medical. 14565.
140 Simpson DA, Cockington RA, Hanieh A, Raftos J, Reilly PL. Head injuries
in infants and young children: the value of the Paediatric Coma Scale.
Review of literature and report on a study. Childs Nerv Syst (1991)
7:18390.[ISI][Medline]
141 Starmark JE, Stalhammar D, Holmgren E. The Reaction Level Scale (RLS85).
Manual and guidelines. Acta Neurochir (Wien) (1988)
91:1220.[CrossRef][Medline]
142 Starmark JE, Stalhammar D, Holmgren E, Rosander B. A comparison of the
Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg (1988)
69:699706.[ISI][Medline]
143 Stiefel MF, Tomita Y, Marmarou A. Secondary ischemia impairing the
restoration of ion homeostasis following traumatic brain injury. J Neurosurg
(2005) 103:70714.[ISI][Medline]
144 Stiell IG, Wells GA, Vandemheen K, et al. The Canadian CT Head Rule for
patients with minor head injury. Lancet (2001)
357:13916.[CrossRef][ISI][Medline]
145 Stocchetti N, Croci M, Spagnoli D, Gilardoni F, Resta F, Colombo A. Mass
volume measurement in severe head injury: accuracy and feasibility of two
pragmatic methods. J Neurol Neurosurg Psychiatry (2000)
68:147.[Abstract/Free Full Text]
146 Sultan HY, Boyle A, Pereira M, Antoun N, Maimaris C. Application of the
Canadian CT head rules in managing minor head injuries in a UK emergency
department: implications for the implementation of the NICE guidelines.
Emerg Med J (2004) 21:42025.[Abstract/Free Full Text]
147 Tatman A, Warren A, Williams A, Powell JE, Whitehouse W. Development of
a modified paediatric coma scale in intensive care clinical practice. Arch
Dis Child (1997) 77:51921.[Abstract/Free Full Text]
148 Teasdale G, Bailey I, Bell A, et al. The effect of nimodipine on outcome
after head injury: a prospective randomised control trial. The
British/Finnish Co-operative Head Injury Trial Group. Acta Neurochir Suppl
(Wien) (1990) 51:3156.[Medline]
149 Teasdale G, Jennett B. Assessment and prognosis of coma after head
injury. Acta Neurochir (Wien) (1976) 34:4555.[CrossRef][Medline]
150 Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A
practical scale. Lancet (1974) 2:814.[CrossRef][ISI][Medline]
151 Teasdale G, Knill-Jones R, van der Sande J. Observer variability in
assessing impaired consciousness and coma. J Neurol Neurosurg Psychiatry
(1978) 41:60310.[Abstract]
152 Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A
randomized, double-blind study of phenytoin for the prevention of
post-traumatic seizures. N Engl J Med (1990) 323:497502.[Abstract]
153 Tennant A. Admission to hospital following head injury in England:
incidence and socio-economic associations. BMC Public Health (2005)
5:21.[CrossRef][Medline]
154 Tennant A. The epidemiology of head injury. In: Traumatic Brain Injury
Rehabilitation: Services, Treatments and OutcomesChamberlain MA, Neumann V,
Tennant A, eds. (1996) London: Chapman Hall.
155 The Association of Anaesthetists of Great Britain and Ireland.
Recommendations for the Safe Transfer of Patients with Brain Injury (2006)
London: The Association of Anaesthetists of Great Britain and Ireland.
156 Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy CW, Penny KI.
Disability in young people and adults one year after head injury:
prospective cohort study. Br Med J (2000) 320:16315.[Abstract/Free Full
Text]
157 Tolias CM, Bullock MR. Critical appraisal of neuroprotection trials in
head injury: what have we learned? NeuroRx (2004) 1:719.[CrossRef][Medline]
158 Trauma Committee of the American College of Surgeons. Advanced Trauma
Life Support Program for Physicians (2004) 7th Edn. Chicago: American
College of Surgeons.
159 Udekwu P, Kromhout-Schiro S, Vaslef S, Baker C, Oller D. Glasgow Coma
Scale score, mortality, and functional outcome in head-injured patients. J
Trauma (2004) 56:10849.[ISI][Medline]
160 Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ.
Insulin therapy protects the central and peripheral nervous system of
intensive care patients. Neurology (2005) 64:134853.[Abstract/Free Full
Text]
161 Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy
in the critically ill patients. N Engl J Med (2001)
345:135967.[Abstract/Free Full Text]
162 Van der Naalt J, Van Zomeren AH, Sluiter WJ, Minderhoud JM. One year
outcome in mild to moderate head injury: the predictive value of acute
injury characteristics related to complaints and return to work. J Neurol
Neurosurg Psychiatry (1999) 66:20713.[Abstract/Free Full Text]
163 Van Dongen KJ, Braakman R, Gelpke GJ. The prognostic value of
computerized tomography in comatose head-injured patients. J Neurosurg
(1983) 59:9517.[ISI][Medline]
164 Van Putten HP, Bouwhuis MG, Muizelaar JP, Lyeth BG, Berman RF.
Diffusion-weighted imaging of edema following traumatic brain injury in
rats: effects of secondary hypoxia. J Neurotrauma (2005)
22:85772.[CrossRef][ISI][Medline]
165 Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for
resuscitation of injured patients with 7.5% sodium chloride. The effect of
added dextran 70. The multicenter group for the study of hypertonic saline
in trauma patients. Arch Surg (1993) 128:100311.[Abstract]
166 Vassar MJ, Perry CA, Gannaway WL, Holcroft JW. 7.5% sodium
chloride/dextran for resuscitation of trauma patients undergoing helicopter
transport. Arch Surg (1991) 126:106572.[Abstract]
167 Vassar MJ, Perry CA, Holcroft JW. Analysis of potential risks associated
with 7.5% sodium chloride resuscitation of traumatic shock. Arch Surg (1990)
125:130915.[Abstract]
168 Vassar MJ, Perry CA, Holcroft JW. Prehospital resuscitation of
hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added
dextran: a controlled trial. J Trauma (1993) 34:62232.[ISI][Medline]
169 Vespa P, Boonyaputthikul R, McArthur DL, et al. Intensive insulin
therapy reduces microdialysis glucose values without altering glucose
utilization or improving the lactate/pyruvate ratio after traumatic brain
injury. Crit Care Med (2006) 34:8506.[CrossRef][ISI][Medline]
170 Vollmer DG, Torner JC, Jane JA. Age and outcome following traumatic
coma: why do older patients fare worse? J Neurosurg (Suppl) (1991)
75:S3749.
171 Vos PE, Battistin L, Birbamer G, et al. EFNS guideline on mild traumatic
brain injury: report of an EFNS task force. Eur J Neurol (2002)
9:20719.[CrossRef][ISI][Medline]
172 Vos PE, van Voskuilen AC, Beems T, Krabbe PF, Vogels OJ. Evaluation of
the traumatic coma data bank computed tomography classification for severe
head injury. J Neurotrauma (2001) 18:64955.[CrossRef][ISI][Medline]
173 Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain
injury. Cochrane Database Syst Rev (2007) 1. doi:10.1002/14651858.
CD001049.pub4.
174 Wardlaw JM, Easton VJ, Statham P. Which CT features help predict outcome
after head injury? J Neurol Neurosurg Psychiatry (2002)
72:18892.[Abstract/Free Full Text]
175 Waters RJ, Nicoll JAR. Genetic influences on outcome following acute
neurological insults. Curr Opin Crit Care (2005)
11:10510.[CrossRef][ISI][Medline]
176 Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J
Anaesth (2007) 99:49.[Abstract/Free Full Text]
177 Winchell RJ, Hoyt DB. Endotracheal intubation in the field improves
survival in patients with severe head injury. Trauma Research and Education
Foundation of San Diego. Arch Surg (1997) 132:5927.[Abstract]
178 Yates PJ, Williams WH, Harris A, Round A, Jenkins R. An epidemiological
study of head injuries in a UK population attending an emergency department.
J Neurol Neurosurg Psychiatry (2006) 77:699701.[Abstract/Free Full Text]
179 Young B, Ott L, Dempsey R, Haack D, Tibbs P. Relationship between
admission hyperglycemia and neurologic outcome of severely brain-injured
patients. Ann Surg (1989) 210:46672.[ISI][Medline]
Information from Industry |
NEW YORK (Reuters Health) Feb 22 - Using high-dose mannitol to treat head injuries may not be a sound strategy as the three main studies supporting this practice may not have even taken place, according to a report in British Medical Journal for February 24.
Between 2001 and 2004, a research group led by Brazilian neurosurgeon Dr. Julio Cruz published three trials showing that high-dose mannitol is preferable to the conventional dose in treating head injury. In particular, a reduction in death and disability was noted at 6 months by using high- rather than standard-dose mannitol.
However, concerns over the data began to surface. In an editorial accompanying one of the studies, the validity and reliability of the findings were called into question, largely because the research was conducted "at only one institution." A later investigation by the Cochrane Collaboration was unable to verify that any of the studies had actually occurred.
In the present report, appearing in the British Medical Journal for February 24, Dr. Ian Roberts, coordinating editor of the Cochrane Injuries Group, and colleagues describe the numerous unsuccessful efforts they took to verify the data from Cruz's studies.
One major problem in confirming the data was that Dr. Cruz committed suicide in 2005. Another problem was that Dr. Roberts' team could not determine where the patients included in the studies had come from. The Federal University of Sao Paulo, which was listed as Dr. Cruz's affiliation on the papers, later told the investigators that it had never employed Dr. Cruz.
Dr. Roberts' team contacted the living co-authors in an effort to retract the reports. These authors declined to seek retraction and supported Dr. Cruz, commenting that "he would never have been able to do something false."
After considerable efforts to confirm the data, Dr. Roberts and colleagues conclude, "We are left with serious doubt about important studies but with no way of determining with confidence whether the results are fabricated or real. The main author is dead. There is no institution to investigate. The implications for patients are serious."
BMJ 2007;334:392-394.
Neurogenic hypotension in patients with severe head injuries.
OBJECTIVE: To examine the occurrence of hypotensive episodes in patients
with severe traumatic brain injuries that are not of hypovolemic origin and
to investigate possible neurogenic or iatrogenic causes of such episodes.
METHODS: We reviewed Traumatic Coma Data Bank (TCDB) records of the 248
patients with early hypotension. We attempted to eliminate episodes related
to hemorrhagic hypovolemia by excluding patients with (1) extracranial
injuries of Abbreviated Injury Scale scores > 3 (n = 99, 40%); (2)
postresuscitation hematocrit levels < 35% (n = 76, 30.6%); (3) hematocrit
levels decreasing to < 35% during the first 24 hours after injury (n = 47,
19%); and (4) patients with conflicting data (n = 5, 2%). This left 21
patients (8.5%) without discernible extracranial causes for their
hypotension. RESULTS: Of these 21 patients, 4 had no extracranial injuries
and 4 had only a single injury with Abbreviated Injury Scale score = 1.
Hypotensive episodes were not associated with terminal or unsalvageable
status. Mortality was 43%. Of the multiple factors investigated, the only
two that were strongly associated with these "unexplained" hypotensive
episodes were the presence of a diffuse injury pattern on computed
tomography (n = 15, 71%) and the early use of mannitol or furosemide (n =
16, 76%) (It was policy at TCDB centers that hypotensive patients not
receive diuretics until they were resuscitated.) CONCLUSIONS: (1) Some
episodes of severe traumatic brain injury-related hypotension may be of
neurogenic origin. (2) The risk/benefit ratio of early diuretic use in
patients with severe traumatic brain injuries may be too high to support
liberal use. These data strongly support the need for a study involving
prospective collection of data describing the early blood pressure courses
in such patients. (J Trauma. 1998 Jun;44(6):958-63)
Isolated brain injury as a cause of hypotension in the blunt trauma patient.
BACKGROUND: Emerging evidence suggests that, contrary to standard teaching,
isolated brain injury may be associated with hypotension. This study sought
to determine the frequency of isolated brain injury-induced hypotension in
blunt trauma victims. METHODS: Hypotensive adult trauma patients were
categorized according to the cause of hypotension: hemorrhagic (hemoglobin <
11.0), neurogenic, isolated brain, or other. Their clinical data and
outcomes were compared. RESULTS: The cause of hypotension was hemorrhagic in
113 (49%), isolated brain injury in 30 (13%), neurogenic in 14 (6%), and
other causes in 24 (10%). Fifty (22%) were indeterminate. Hemorrhagic,
isolated brain, and neurogenic groups were similar in age, Injury Severity
Score, and systolic blood pressure. The Glasgow Coma Scale score of the
isolated brain group was lower than in the hemorrhagic group (4.4 vs. 8.4, p
< 0.05). Mortality was higher in the isolated brain group compared with the
hemorrhagic group (80% vs. 50%, p < 0.05) and in the subgroup of hemorrhagic
patients with versus without associated brain injury (57% vs. 39%, p <
0.05). CONCLUSION: Isolated brain injuries account for 13% of hypotensive
events after blunt trauma and are associated with an increased mortality
compared with hemorrhage-induced hypotension. In hypotensive brain-injured
patients, hemorrhagic sources should be excluded rapidly, and the focus
should be on resuscitation. (J Trauma. 2003 Dec;55(6):1065-9)
Conclusions: This data suggests that EDH or SDH <1 cm thick can be safely managed nonoperatively unless there is concomitant CE.
ICP changes in a limited number of patterns after TBI 9:
In 1965, Nils Lundberg et al. characterized ICP slow waves.51 A waves or plateau waves are steep increases in ICP from baseline to peaks of 50-80 mm Hg that persist for 5-20 min. These waves are always pathologic and may be associated with early signs of brain herniation, such as bradycardia and hypertension. They occur in patients with intact autoregulation and reduced intracranial compliance and represent reflex, phasic vasodilatation in response to reduced cerebral perfusion.52,53 The development of plateau waves leads to a vicious cycle, with reductions in CPP predisposing to the development of more plateau waves, further reductions in CPP and irreversible cerebral ischemia. B waves are rhythmic oscillations occurring at 0.5-2 waves/min with peak ICP increasing to around 20-30 mm Hg above baseline. They are related to changes in vascular tone, probably due to vasomotor instability